Such investigations would help determine whether CDCA5 and MCTS1 are uniquely associated with SLE or represent common elements of immune dysregulation across autoimmune conditions, thereby improving the precision and clinical applicability of these biomarkers. The gene discussed is CDCA5; the disease is systemic lupus erythematosus.